Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Persimmon Broker Ratings



Broker Ratings for Persimmon (PSN)


Share Price: 2,623.00Bid: 2,780.00Ask: 2,465.00Change: -52.00 (-1.94%)Faller - Persimmon
Spread: -315.00Spread as %: -11.33%Open: 2,679.00High: 2,691.00Low: 2,597.00Yesterday’s Close: 2,675.00


Broker Recommendations for Persimmon (PSN)
DateBrokerRatingOld TargetNew TargetChange
08-Nov-17Canaccord GenuityHold2,650.002,650.00Reiteration
06-Nov-17JP Morgan CazenoveOverweight2,800.002,800.00Reiteration
27-Oct-17BarclaysUnderweight2,566.002,711.00Downgrade
12-Sep-17Bank of AmericaUnderperform2,230.002,230.00Reiteration
23-Aug-17JefferiesHold2,316.002,442.00Reiteration
23-Aug-17Canaccord GenuityHold2,570.002,650.00Downgrade
22-Aug-17Canaccord GenuityBuy-2,570.00Reiteration
13-Jul-17BarclaysEqual-weight2,123.002,566.00Reiteration
06-Jul-17Numis SecuritiesHold2,413.002,523.00Reiteration
06-Jul-17JP Morgan CazenoveOverweight2,400.002,600.00Reiteration
04-Jul-17DeutscheHold-2,340.00Reiteration
29-Jun-17CitigroupNeutral-2,265.00Reiteration
26-Jun-17JefferiesHold2,102.002,316.00Reiteration
09-Jun-17Liberum CapitalHold-2,161.00Reiteration
31-May-17DeutscheHold2,313.002,340.00Reiteration


Registered members see more Persimmon broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.